Authors: Helle, SI Ueland, T Ekse, D Froland, SS Holly, JMP Lonning, PE Aukrust, P

Citation: Si. Helle et al., The insulin-like growth factor system in human immunodeficiency virus infection: Relations to immunological parameters, disease progression, and antiretroviral therapy, J CLIN END, 86(1), 2001, pp. 227-233

Authors: Helle, SI Geisler, J Anker, GB Leirvaag, B Holly, JMP Lonning, PE

Citation: Si. Helle et al., Alterations in the insulin-like growth factor system during treatment withdiethylstilboestrol in patients with metastatic breast cancer, BR J CANC, 85(2), 2001, pp. 147-151

Authors: Helle, SI Geisler, S Aas, T Paulsen, T Holly, JMP Lonning, PE

Citation: Si. Helle et al., Plasma insulin-like growth factor binding protein-3 proteolysis is increased in primary breast cancer, BR J CANC, 85(1), 2001, pp. 74-77

Authors: Helle, SI Lundgren, S Geisler, S Ekse, D Holly, JMP Lonning, PE

Citation: Si. Helle et al., Effects of treatment with megestrol acetate on the insulin-like growth factor system: Time and dose dependency, EUR J CANC, 35(7), 1999, pp. 1070-1075

Authors: Geisler, J Omsjo, IH Helle, SI Ekse, D Silsand, T Lonning, PE

Citation: J. Geisler et al., Plasma oestrogen fractions in postmenopausal women receiving hormone replacement therapy: influence of route of administration and cigarette smoking, J ENDOCR, 162(2), 1999, pp. 265-270

Authors: Diamandis, EP Helle, SI Yu, H Melegos, DN Lundgren, S Lonning, PE

Citation: Ep. Diamandis et al., Prognostic value of plasma prostate specific antigen after megestrol acetate treatment in patients with metastatic breast carcinoma, CANCER, 85(4), 1999, pp. 891-898